NYVCX
Price
$20.59
Change
+$0.21 (+1.03%)
Updated
Jan 17 closing price
Net Assets
6.54B
VFIAX
Price
$553.67
Change
+$5.49 (+1.00%)
Updated
Jan 17 closing price
Net Assets
1.35T
Ad is loading...

NYVCX vs VFIAX

Header iconNYVCX vs VFIAX Comparison
Open Charts NYVCX vs VFIAXBanner chart's image
Davis NY Venture C
Price$20.59
Change+$0.21 (+1.03%)
VolumeN/A
Net Assets6.54B
Vanguard 500 Index Admiral
Price$553.67
Change+$5.49 (+1.00%)
VolumeN/A
Net Assets1.35T
NYVCX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NYVCX vs. VFIAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYVCX is a Hold and VFIAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.35T vs. NYVCX (6.54B). VFIAX pays higher dividends than NYVCX: VFIAX (1.32) vs NYVCX (0.12). NYVCX was incepted earlier than VFIAX: NYVCX (30 years) vs VFIAX (24 years). NYVCX is a more actively managed with annual turnover of: 7.00 vs. VFIAX (2.00). NYVCX has a lower initial minimum investment than VFIAX: NYVCX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 25.54 vs. NYVCX (-1.50). VFIAX return over 5 years is better than : 80.23 vs. NYVCX (-21.85).
NYVCXVFIAXNYVCX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years24 years-
Gain YTD3.5192.010175%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets6.54B1.35T0%
Annual Yield % from dividends0.121.329%
Returns for 1 year-1.5025.54-6%
Returns for 3 years-16.3531.13-53%
Returns for 5 years-21.8580.23-27%
Returns for 10 years-37.22196.98-19%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.790.45
+7.10%
LexinFintech Holdings Ltd
GATX154.690.58
+0.38%
GATX Corp
ALC84.370.23
+0.27%
Alcon
ANTX1.27N/A
N/A
AN2 Therapeutics
NMM42.48-1.07
-2.46%
Navios Maritime Partners LP